Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marjatta Nurminen is active.

Publication


Featured researches published by Marjatta Nurminen.


Molecular Microbiology | 2006

The class 1 outer membrane protein of Neisseria meningitidis produced in Bacillus subtilis can give rise to protective immunity

Marjatta Nurminen; Sarah Butcher; IIona Idänpään-Heikkilä; Eva Wahlström; Susanna Muttilainen; Kate Runeberg-Nyman; Matti Sarvas; P. Helena Mäkelä

The class 1 outer membrane protein of Neisseria meningitidis B:15:P1.7, 16 was expressed in Bacillus subtilis in high yield as intracellular aggregates. These were easy to isolate and the protein (called BacP1) could be solubilized under denaturing conditions. Sera of mice immunized with thus‐solubilized BacP1 contained high titres of antibodies that reacted with the class 1 protein of the meningococcal envelope in immunoblots but did not react with native meningococcal envelope in enzyme immunoassays (EIA) or with intact meningococci in bactericidal assays. However, when the BacP1 protein was complexed with heterologous (Salmonella) lipopolysaccharide, the ensuing sera reacted with meningococcal envelope preparations in both EIA and immunoblots, showed subtype‐specific bactericidal activity, and were protective in an infant rat meningitis model.


Vaccine | 1996

Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100

Ilona Idänpään-Heikkilä; Eva Wahlström; Susanna Muttilainen; Marjatta Nurminen; H. Käyhty; Matti Sarvas; P.H. Mäkelä

Vaccines against group B meningococcal infection tested in several field trials have all been extracts of the outer membrane of the bacteria. We have developed a single component vaccine based on the class 1 outer membrane protein P1 produced in a heterologous host Bacillus subtilis, and describe here its immunizing properties. The purified and denatured protein BacP1 was solubilized in SDS, followed by addition of an excess of a second detergent (Zwittergent 3-14 or Triton X-100). Immunization of mice showed that this process led to at least partial reconstitution of the native epitopes of the P1 protein. The immunogenicity of these BacP1 detergent preparations was further improved when administered together with adjuvants (aluminium hydroxide or monophosphoryl lipid A); high titers of antibodies were thus obtained with vaccine doses as low as 2 micrograms of protein. The antibodies elicited were essentially of IgG and reactive with protective epitopes present on the surface of meningococci. The bactericidal activity of the sera showed a good correlation to antibodies of the IgG1 and IgG2 isotypes, concomitantly increased in most sera.


Archive | 1991

Salmonella as an Invasive Enteric Pathogen

P. Helena Mäkelä; Marianne Hovi; Harri Saxen; Anna Muotiala; Petri Riikonen; Marjatta Nurminen; Suvi Taira; Soila Sukupolvi; Mikael Rhen

Salmonella can infect a surprisingly wide variety of hosts ranging from reptiles to birds to mammals. Yet the bacteria isolated are so close to each other in DNA sequence that they must be considered as one species. The species name is at this moment still uncertain, because of the earlier separation of its many serovars as species, and the familiarity of their names to both microbiologists and clinicians. A new name. Salmonella enterica, has therefore been proposed to cover the whole species, but this name has not (yet) been accepted.[1] The use of the serovar names as trivial names is a practical compromise, also adopted in this paper.


The Journal of Infectious Diseases | 1984

Chlamydial pneumonitis and its serodiagnosis in infants.

Mirja Puolakkainen; Pekka Saikku; Maija Leinonen; Marjatta Nurminen; Pertti Väänänen; P. Helena Mäkelä


Microbial Pathogenesis | 1995

TheNeisseria meningitidisouter membrane protein P1 produced inBacillus subtilisand reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes

Susanna Muttilainen; Ilona Idänpään-Heikkilä; Eva Wahlström; Marjatta Nurminen; Mäkelä Ph; Matti Sarvas


FEBS Journal | 1971

The Smooth Lipopolysaccharide Character of 1,4,(5),12 and 1,9,12 Transductants Formed as Hybrids between Groups B and D of Salmonella

Marjatta Nurminen; Carl Gustaf Hellerqvist; Ville V. Valtonen; P. Helena Mäkelä


Microbial Pathogenesis | 1995

Heterologous production of the P1 porin of Neisseria meningitidis in Bacillus subtilis : the effect of an N-terminal extension on the presentation of native-like epitopes

Susanna Muttilainen; Sarah Butcher; Kate Runeberg; Marjatta Nurminen; Ilona Idänpään-Heikkilä; Eva Wahlström; Matti Sarvas


Fems Microbiology Letters | 1984

The effect of mercaptoethanol on the solubilization of the 39.5 kDa major outer membrane protein of elementary bodies of Chlamydia trachomatis and purification of the protein

Marjatta Nurminen; Kari Lounatmaa; Maija Leinonen; Eva Wahlström


Fems Microbiology Letters | 1991

The role of the O antigen in adjuvant activity of lipopolysaccharide

Marjatta Nurminen; Rose-Marie Ölander


Fems Microbiology Letters | 1984

Processing of McCoy cell cultures infected with Chlamydia trachomatis: sequential isolation of chlamydial elementary bodies and lipopolysaccharide

Eva Wahlström; Pertti Väänänen; Pekka Saikku; Marjatta Nurminen

Collaboration


Dive into the Marjatta Nurminen's collaboration.

Top Co-Authors

Avatar

Eva Wahlström

University of Copenhagen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maija Leinonen

National Institute for Health and Welfare

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Harri Saxen

University of Helsinki

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge